Please use this identifier to cite or link to this item:
|Title:||Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data|
|Citation:||The Lancet, Vol. 387, No. 10013, p61–69|
|Appears in Collections:||Institute of Community and Public Health|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.